Trial reportPediatric research2026
Effect of S-ketamine on postoperative pain sensitivity in children with preoperative chemotherapy.
Trial report in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChildren undergoing chemotherapy experience exacerbated postoperative pain and prolonged pain perception. Intraoperative intravenous administration of S-ketamine can alleviate postoperative pain. However, its efficacy in mitigating chemotherapy-induced hyperalgesia remains uncertain. This study evaluates the effect of S-ketamine on postoperative pain sensitivity in children who received preoperative chemotherapy.
methodsA total of 40 children undergoing preoperative chemotherapy and scheduled for open abdominal surgery were recruited from our center and randomly assigned to either the S-ketamine group or the control group. The primary outcomes included postoperative mechanical pain threshold, FLACC scale, Wong-Baker FACES pain rating scale (WBS), and cases of additional analgesic use. Secondary outcomes included intraoperative hemodynamic changes, extubation time, and incidence of adverse events.
resultsThirty-six children were included in the study. The two groups had no significant difference in preoperative mechanical pain thresholds (P = 0.585). Patients receiving S-ketamine had higher mechanical pain thresholds at 24 and 48 h post-surgery (both P < 0.001). Preoperative FLACC and WBS were 0 in both groups. Postoperative FLACC and WBS showed significant differences at various time points (all P < 0.05). There is a negative correlation between infusion time of S-ketamine and postoperative mechanical pain threshold at 24 h (r = -0.570, P = 0.014) and 48 h postoperatively (r = -0.643, P = 0.004) in the S-ketmanie group.
conclusionIntravenous S-ketamine significantly increases postoperative mechanical pain threshold and reduces pain in patients who received neoadjuvant chemotherapy. IMPACT: Children undergoing chemotherapy experience exacerbated postoperative pain and prolonged pain perception. Intraoperative intravenous administration of S-ketamine can alleviate postoperative pain. However, its efficacy in mitigating chemotherapy-induced hyperalgesia remains uncertain. This study fills the gap in this area. This study evaluates the effect of S-ketamine on postoperative pain sensitivity in children who received preoperative chemotherapy. S-ketamine's NMDAR antagonism may partly reduce pain sensitivity, thus reversing the pain effect. The results of this study provide promising evidence for the potential benefits of S-ketamine in improving postoperative pain outcomes in this patient population. The infusion time of S-ketamine ranged from 30 to 655 min, suggesting that the beneficial effect can be achieved within this time frame.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.